These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 15123532

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Prevalence of the glucose metabolism disturbances in screening of adult inhabitants of Krakow].
    Szurkowska M, Szafraniec K, Gilis-Januszewska A, Pach D, Krzentowska A, Szybiński Z, Huszno B.
    Przegl Lek; 2006; 63(9):728-32. PubMed ID: 17479858
    [Abstract] [Full Text] [Related]

  • 27. Incidence of new-onset diabetes and impaired fasting glucose in patients with recent myocardial infarction and the effect of clinical and lifestyle risk factors.
    Mozaffarian D, Marfisi R, Levantesi G, Silletta MG, Tavazzi L, Tognoni G, Valagussa F, Marchioli R.
    Lancet; 2007 Aug 25; 370(9588):667-75. PubMed ID: 17720018
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Long-term beneficial effects of glipizide treatment on glucose tolerance in subjects with impaired glucose tolerance.
    Eriksson JG, Lehtovirta M, Ehrnström B, Salmela S, Groop L.
    J Intern Med; 2006 Jun 25; 259(6):553-60. PubMed ID: 16704555
    [Abstract] [Full Text] [Related]

  • 30. Impaired glucose metabolism in colorectal cancer.
    Ehrmann-Jósko A, Siemińska J, Górnicka B, Ziarkiewicz-Wróblewska B, Ziółkowski B, Muszyński J.
    Scand J Gastroenterol; 2006 Sep 25; 41(9):1079-86. PubMed ID: 16938722
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Asymptomatic hyperglycemia in coronary heart disease: frequency and associated lipid and lipoprotein levels in the bezafibrate infarction prevention (BIP) register. The BIP Study Group.
    Behar S, Boyko V, Benderly M, Mandelzweig L, Graff E, Reicher-Reiss H, Schneider H, Shotan A, Balkin J, Brunner D.
    J Cardiovasc Risk; 1995 Jun 25; 2(3):241-6. PubMed ID: 7584800
    [Abstract] [Full Text] [Related]

  • 33. Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study.
    Buyken AE, von Eckardstein A, Schulte H, Cullen P, Assmann G.
    Eur J Cardiovasc Prev Rehabil; 2007 Apr 25; 14(2):230-6. PubMed ID: 17446801
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Does glucose level at hospital discharge predict one-year mortality in patients with diabetes mellitus treated with percutaneous coronary intervention for ST-segment elevation myocardial infarction?
    Gasior M, Pres D, Stasik-Pres G, Lech P, Gierlotka M, Lekston A, Hawranek M, Tajstra M, Kalarus Z, Poloński L.
    Kardiol Pol; 2008 Jan 25; 66(1):1-8; discussion 9-11. PubMed ID: 18266182
    [Abstract] [Full Text] [Related]

  • 37. Blood glucose and cerebrovascular disease in nondiabetic patients.
    Nielson C, Fleming RM.
    Angiology; 2007 Jan 25; 58(5):625-9. PubMed ID: 18024949
    [Abstract] [Full Text] [Related]

  • 38. Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level.
    Hiuge A, Tenenbaum A, Maeda N, Benderly M, Kumada M, Fisman EZ, Tanne D, Matas Z, Hibuse T, Fujita K, Nishizawa H, Adler Y, Motro M, Kihara S, Shimomura I, Behar S, Funahashi T.
    Arterioscler Thromb Vasc Biol; 2007 Mar 25; 27(3):635-41. PubMed ID: 17194889
    [Abstract] [Full Text] [Related]

  • 39. Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease.
    Koga H, Sugiyama S, Kugiyama K, Fukushima H, Watanabe K, Sakamoto T, Yoshimura M, Jinnouchi H, Ogawa H.
    Eur Heart J; 2006 Apr 25; 27(7):817-23. PubMed ID: 16434416
    [Abstract] [Full Text] [Related]

  • 40. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Barzilay JI, Davis BR, Cutler JA, Pressel SL, Whelton PK, Basile J, Margolis KL, Ong ST, Sadler LS, Summerson J, ALLHAT Collaborative Research Group.
    Arch Intern Med; 2006 Nov 13; 166(20):2191-201. PubMed ID: 17101936
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.